Insider trading

Period: 120 months Stock: KALA + Add filter Clear all

Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in

When Periodin use

Who Role

The trade Type of trade Minimum amount Plan Share of their own holding

Ownership What the chief executive holds

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months

104 decisions over 120 months

Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners

104 decisions over 120 months

The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any104 Buys31 Sells73 Cluster buys

104 decisions over 120 months

The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more

104 decisions over 120 months

The trade

Plan

Discretionary: they chose to sell that week.
Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.

Any Discretionary Scheduled (10b5-1) Not stated Not on a plan

104 decisions over 120 months

The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

104 decisions over 120 months

Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

104 decisions over 120 months

Stock

Insider

Type ?

Of own stake ↓

Why it stands out

KALA KALA BIO, Inc.

27 Jun 2022

Bazemore Todd SEE REMARKS

Sold, plan not stated

$1.14K 3,092 at 0.37

2.6%

KALA KALA BIO, Inc.

27 Jun 2022

Trachtenberg Eric SEE REMARKS

Sold, plan not stated

$966.81 2,613 at 0.37

2.3%

KALA KALA BIO, Inc.

27 Jun 2022

Reumuth Mary CHIEF FINANCIAL OFFICER

Sold, plan not stated

$966.81 2,613 at 0.37

2.0%

KALA KALA BIO, Inc.

26 May 2022

RA CAPITAL MANAGEMENT, L.P. 10% owner · indirect

Sold, plan not stated

$365.67K 1,005,686 at 0.36

12.5%

KALA KALA BIO, Inc.

25 May 2022

RA CAPITAL MANAGEMENT, L.P. 10% owner · indirect

Sold, plan not stated

$602.49K 1,434,509 at 0.42

15.1%

KALA KALA BIO, Inc.

24 May 2022

RA CAPITAL MANAGEMENT, L.P. 10% owner · indirect

Sold, plan not stated

$73.85K 144,805 at 0.51

1.5%

KALA KALA BIO, Inc.

23 May 2022

RA CAPITAL MANAGEMENT, L.P. 10% owner · indirect

Sold, plan not stated

$812.50K 1,250,000 at 0.65

11.5%

KALA KALA BIO, Inc.

4 Jan 2022

Iwicki Mark T CHIEF EXECUTIVE OFFICER

Sold, plan not stated

$12.37K 9,518 at 1.30

3.5%

KALA KALA BIO, Inc.

4 Jan 2022

Brazzell Romulus K SEE REMARKS

Sold, plan not stated

$4.56K 3,504 at 1.30

1.2%

KALA KALA BIO, Inc.

4 Jan 2022

Bazemore Todd SEE REMARKS

Sold, plan not stated

$4.49K 3,454 at 1.30

2.8%

KALA KALA BIO, Inc.

4 Jan 2022

Reumuth Mary CHIEF FINANCIAL OFFICER

Sold, plan not stated

$3.71K 2,850 at 1.30

2.1%

KALA KALA BIO, Inc.

4 Jan 2022

Trachtenberg Eric SEE REMARKS

Sold, plan not stated

$3.71K 2,850 at 1.30

2.4%

KALA KALA BIO, Inc.

27 Oct 2021

Chen Hongming CHIEF SCIENTIFIC OFFICER

Sold, plan not stated

$38.31K 21,051 at 1.82

9.3%

KALA KALA BIO, Inc.

26 Oct 2021

Iwicki Mark T CHIEF EXECUTIVE OFFICER

Sold, plan not stated

$49.68K 27,598 at 1.80

9.3%

KALA KALA BIO, Inc.

26 Oct 2021

Brazzell Romulus K CHIEF MEDICAL OFFICER

Sold, plan not stated

$22.96K 12,757 at 1.80

4.2%

KALA KALA BIO, Inc.

26 Oct 2021

Bazemore Todd CHIEF OPERATING OFFICER

Sold, plan not stated

$22.58K 12,544 at 1.80

9.3%

KALA KALA BIO, Inc.

26 Oct 2021

Chen Hongming CHIEF SCIENTIFIC OFFICER

Sold, plan not stated

$17.01K 9,449 at 1.80

4.0%

KALA KALA BIO, Inc.

26 Oct 2021

Trachtenberg Eric SEE REMARKS

Sold, plan not stated

$17.01K 9,449 at 1.80

7.5%

KALA KALA BIO, Inc.

26 Oct 2021

Reumuth Mary CHIEF FINANCIAL OFFICER

Sold, plan not stated

$17.01K 9,449 at 1.80

6.5%

KALA KALA BIO, Inc.

29 Jun 2021

Chen Hongming CHIEF SCIENTIFIC OFFICER

Sold, plan not stated

$30.85K 5,548 at 5.56

2.3%

KALA KALA BIO, Inc.

28 Jun 2021

Iwicki Mark T CHIEF EXECUTIVE OFFICER

Sold, plan not stated

$43.77K 7,586 at 5.77

2.5%

KALA KALA BIO, Inc.

28 Jun 2021

Brazzell Romulus K CHIEF MEDICAL OFFICER

Sold, plan not stated

$17.51K 3,034 at 5.77

1.0%

KALA KALA BIO, Inc.

28 Jun 2021

Chen Hongming CHIEF SCIENTIFIC OFFICER

Sold, plan not stated

$14.15K 2,452 at 5.77

1.0%

KALA KALA BIO, Inc.

28 Jun 2021

Trachtenberg Eric SEE REMARKS

Sold, plan not stated

$14.15K 2,452 at 5.77

1.9%

KALA KALA BIO, Inc.

28 Jun 2021

Reumuth Mary CHIEF FINANCIAL OFFICER

Sold, plan not stated

$14.15K 2,452 at 5.77

1.7%

KALA KALA BIO, Inc.

22 Oct 2020

Bazemore Todd Chief Operating Officer · indirect

Bought

$304.00 40 at 7.60

×20

First buy on file

KALA KALA BIO, Inc.

5 Jun 2020

Bazemore Todd Chief Operating Officer · indirect

Bought

$26.78 2 at 13.39

opened

First buy on file

KALA KALA BIO, Inc.

16 Mar 2020

Bazemore Todd Chief Operating Officer

Bought

$57.50K 10,000 at 5.75

opened

First buy on file

KALA KALA BIO, Inc.

13 Mar 2020

Shah Rajeev M. Director · indirect

Bought

$50.00M 6,337,135 at 7.89

140%

First buy on file

KALA KALA BIO, Inc.

13 Mar 2020

RA CAPITAL MANAGEMENT, L.P. Director · indirect

Bought

$50.00M 6,337,135 at 7.89

140%

First buy on file

KALA KALA BIO, Inc.

13 Mar 2020

Grunberg Gregory Director · indirect

Bought

$20.00M 2,534,854 at 7.89

opened

First buy on file

KALA KALA BIO, Inc.

30 May 2019

Rosen Howard B Director

Bought

$27.10K 5,000 at 5.42

154%

First buy on file

KALA KALA BIO, Inc.

5 Oct 2018

Grunberg Gregory Director · indirect

Bought

$5.00M 606,060 at 8.25

26.7%

First buy on file

KALA KALA BIO, Inc.

3 Oct 2018

Shah Rajeev M. Director · indirect

Bought

$20.00M 2,424,242 at 8.25

115%

First buy on file

KALA KALA BIO, Inc.

3 Oct 2018

RA CAPITAL MANAGEMENT, L.P. Director · indirect

Bought

$20.00M 2,424,242 at 8.25

115%

First buy on file

KALA KALA BIO, Inc.

8 Feb 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$323.25K 25,000 at 12.93

0.7%

First buy on file

KALA KALA BIO, Inc.

2 Feb 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$557.38K 37,840 at 14.73

1.1%

First buy on file

KALA KALA BIO, Inc.

1 Feb 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$342.37K 22,840 at 14.99

0.7%

First buy on file

KALA KALA BIO, Inc.

31 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$5.09M 339,400 at 15.00

11.2%

First buy on file

KALA KALA BIO, Inc.

29 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$749.50K 50,000 at 14.99

1.7%

First buy on file

KALA KALA BIO, Inc.

26 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$339.81K 22,760 at 14.93

0.8%

First buy on file

KALA KALA BIO, Inc.

24 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$963.74K 64,637 at 14.91

2.2%

First buy on file

KALA KALA BIO, Inc.

23 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$65.40K 4,363 at 14.99

0.2%

First buy on file

KALA KALA BIO, Inc.

22 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$1.12M 75,000 at 14.98

2.7%

First buy on file

KALA KALA BIO, Inc.

19 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$1.12M 74,931 at 14.95

2.7%

First buy on file

KALA KALA BIO, Inc.

12 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought 2×

$994.20K 66,800 at 14.88

2.5%

First buy on file

KALA KALA BIO, Inc.

11 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$569.21K 41,700 at 13.65

1.6%

First buy on file

KALA KALA BIO, Inc.

10 Jan 2018

ORBIMED ADVISORS LLC 10% owner · indirect

Bought

$2.19M 170,338 at 12.83

6.9%

First buy on file

KALA KALA BIO, Inc.

25 Jul 2017

RA CAPITAL MANAGEMENT, L.P. Director · indirect

Bought

$8.00M 533,333 at 15.00

33.8%

First buy on file

KALA KALA BIO, Inc.

25 Jul 2017

Shah Rajeev M. Director · indirect

Bought

$8.00M 533,333 at 15.00

33.8%

First buy on file

Showing 51–100 of 104.